Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,299 papers from all fields of science
Search
Sign In
Create Free Account
recombinant antihemophilic factor VIII
Known as:
recombinant factor viii
, rfviii
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Narrower (6)
Antihemophilic Factor, Human Recombinant
Humate-P
Kogenate
Octocog alfa
Expand
Antihemophilic Factor, Human Recombinant 1 UNT Injection
Antihemophilic Factor, Human Recombinant 1 UNT Injection [Recombinate]
Broader (1)
Factor VIII
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Adsorption and function of recombinant factor VIII at solid-water interfaces in the presence of Tween-80.
O. Joshi
,
J. Mcguire
,
D. Q. Wang
Journal of Pharmacy and Science
2008
Corpus ID: 22088244
The adsorption, structural alteration and biological activity of a recombinant Factor VIII was investigated in the presence of…
Expand
2007
2007
Defining ‘full‐length’ recombinant factor VIII: a comparative structural analysis
M. Jankowski
,
H. Patel
,
J. Rouse
,
L. Marzilli
,
S. B. Weston
,
P. Sharpe
Haemophilia
2007
Corpus ID: 24243231
Summary. Coagulation factor VIII (FVIII) is an important glycoprotein co‐factor involved in haemostasis, functioning to…
Expand
Review
2006
Review
2006
Recombinant vs. plasma‐derived products, especially those with intact VWF, regarding inhibitor development
C. Ettingshausen
,
W. Kreuz
Haemophilia
2006
Corpus ID: 20482271
Summary. The development of inhibitors in previously untreated patients (PUPs) with haemophilia A is correlated with a variety…
Expand
Review
2004
Review
2004
New high‐technology products for the treatment of haemophilia
S. Pipe
,
J. Saint-Remy
,
C. Walsh
Haemophilia
2004
Corpus ID: 21238450
Summary. This review will focus on new technologies in development that promise to lead to further advances in haemophilia…
Expand
2004
2004
Inhibitor development in patients receiving recombinant factor VIII (Recombinate rAHF/Bioclate®): a prospective pharmacovigilance study
B. Ewenstein
,
E. Gomperts
,
S. Pearson
,
M. E. O’Banion
Haemophilia
2004
Corpus ID: 21206913
Summary. Clinical trials to date have not been adequately powered to assess comparatively infrequent events such as inhibitor…
Expand
2001
2001
Potency estimation of recombinant factor VIII: effect of assay method and standard
A. Hubbard
,
S. Bevan
,
L. Weller
British Journal of Haematology
2001
Corpus ID: 26642678
Large potency discrepancies between the chromogenic and one‐stage clotting methods have been reported for patients' plasma…
Expand
Highly Cited
1998
Highly Cited
1998
A prospective clinical trial of implantable central venous access in children with haemophilia
Santagostino
,
Gringeri
,
MuçA‐Perja
,
Mannucci
British Journal of Haematology
1998
Corpus ID: 33183415
To assess the risks associated with the use of central venous ports in children with haemophilia, 15 HIV‐negative patients were…
Expand
Highly Cited
1997
Highly Cited
1997
A Multicenter Pharmacosurveillance Study for the Evaluation of the Efficacy and Safety of Recombinant Factor VIII in the Treatment of Patients with Hemophilia A
E. Aygören‐Pürsün
,
I. Scharrer
Thrombosis and Haemostasis
1997
Corpus ID: 25670904
Summary In this open multicenter study the safety and efficacy of recombinant factor VIII (rFVIII) was assessed in 39 previously…
Expand
1990
1990
Characterization of recombinant factor VIII and a recombinant factor VIII deletion mutant using a rabbit immunogenicity model system.
P. Esmon
,
H. Kuo
,
M. Fournel
Blood
1990
Corpus ID: 38808196
The use of factor VIII prepared genetically engineered cell lines (rFVIII) may avoid some of the problems inherently associated…
Expand
Highly Cited
1987
Highly Cited
1987
Characterization of recombinant human factor VIII.
Dan L. Eaton
,
Philip E. Hass
,
+4 authors
G. Vehar
Journal of Biological Chemistry
1987
Corpus ID: 22617751
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE